CN Patent

CN101309917B — 具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂

Assigned to Auspex Pharmaceuticals Inc · Expires 2013-09-11 · 13y expired

What this patent protects

本发明描述了式1的胃H + ，K + -ATP酶氘代抑制剂的化学合成和用于治疗和/或控制十二指肠溃疡、胃灼热、酸反流、由胃酸分泌介导的其他疾病和/或银屑病的医学应用。

USPTO Abstract

本发明描述了式1的胃H + ，K + -ATP酶氘代抑制剂的化学合成和用于治疗和/或控制十二指肠溃疡、胃灼热、酸反流、由胃酸分泌介导的其他疾病和/或银屑病的医学应用。

Drugs covered by this patent

lumateperone-tosylate (LUMATEPERONE TOSYLATE)

Patent Metadata

Patent number: CN101309917B
Jurisdiction: CN
Classification: —
Expires: 2013-09-11
Drug substance claim: No
Drug product claim: No
Assignee: Auspex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.